Tsai C-Y, Yeh C-J, Chao Y-K, Chang H-K, Tseng C-K, Liu Y-H
Division of Thoracic Surgery, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Department of Pathology, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Eur J Surg Oncol. 2017 Oct;43(10):1970-1976. doi: 10.1016/j.ejso.2017.07.014. Epub 2017 Aug 3.
The prognostic impact of perineural invasion (PNI) in patients with esophageal cancer who receive neoadjuvant chemoradiotherapy (nCRT) remains unclear.
A thorough pathological review of PNI was performed on post-nCRT esophagectomy specimens obtained from non-ypT0 patients with esophageal squamous cell carcinoma (ESCC). When PNI was identified, it was classified according to the presence or absence of penetration through the nerve sheath (i.e., PNI surrounding the nerve sheath [PNI-SS] versus PNI penetrating through the nerve sheath [PNI-TS]). The impact of PNI on overall survival (OS) was assessed in combination with clinical and pathological risk factors.
A total of 177 eligible patients were identified between 1998 and 2008. PNI was identified in 43.5% (77/177) of participants. Of them, 33 and 44 had PNI-SS and PNI-TS, respectively. The 5-year OS rate of patients with PNI-TS was significantly lower (6.7%) than that observed in those without PNI (30.6%, P < 0.001). However, the 5-year OS observed in the latter group did not differ significantly from that of patients with PNI-SS (26%, P = 0.68). Multivariate analysis identified PNI-TS (hazard ratio [HR] = 1.965, P = 0.02), LVI (HR = 1.514, P = 0.048), and ypN2 stage (HR = 2.39, P = 0.007) as independent adverse prognostic factors for OS.
The presence of PNI-TS after nCRT is associated with poor survival. A thorough assessment of distinct PNI patterns (i.e., PNI-TS versus PNI-SS) should be part of the routine post-nCRT histopathological work-up of ESCC patients.
新辅助放化疗(nCRT)的食管癌患者中,神经周围浸润(PNI)的预后影响尚不清楚。
对非ypT0食管鳞状细胞癌(ESCC)患者接受nCRT后食管切除标本进行PNI的全面病理检查。当识别出PNI时,根据是否穿透神经鞘进行分类(即围绕神经鞘的PNI [PNI-SS]与穿透神经鞘的PNI [PNI-TS])。结合临床和病理危险因素评估PNI对总生存期(OS)的影响。
1998年至2008年间共确定了177例符合条件的患者。43.5%(77/177)的参与者被识别出有PNI。其中,分别有33例和44例有PNI-SS和PNI-TS。PNI-TS患者的5年总生存率(6.7%)显著低于无PNI患者(30.6%,P < 0.001)。然而,后一组观察到的5年总生存率与PNI-SS患者(26%)无显著差异(P = 0.68)。多因素分析确定PNI-TS(风险比[HR] = 1.965,P = 0.02)、淋巴管浸润(LVI,HR = 1.514,P = 0.048)和ypN2期(HR = 2.39,P = 0.007)是OS的独立不良预后因素。
nCRT后PNI-TS的存在与生存不良相关。对不同PNI模式(即PNI-TS与PNI-SS)的全面评估应成为ESCC患者nCRT后常规组织病理学检查的一部分。